PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-117.45%
Both yoy net incomes decline, with CSIQ at -6.94%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-32.11%
Negative yoy D&A while CSIQ is 0.00%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-38525.00%
Negative yoy deferred tax while CSIQ stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-20.65%
Both cut yoy SBC, with CSIQ at -20.00%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
126.73%
Working capital change of 126.73% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
104.80%
AR growth of 104.80% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-125.59%
Negative yoy inventory while CSIQ is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
111.69%
AP growth of 111.69% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
-69.46%
Negative yoy usage while CSIQ is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
73.95%
Well above CSIQ's 7.63%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
55.50%
CFO growth of 55.50% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a modest edge that could widen if cost discipline remains strong.
-52.66%
Negative yoy CapEx while CSIQ is 0.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-111.53%
Negative yoy acquisition while CSIQ stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
17330.70%
Growth of 17330.70% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
707.59%
We expand invests by 707.59% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a moderate outflow that must be justified by returns vs. competitor’s stable approach.
-83.41%
We cut debt repayment yoy while CSIQ is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
40.77%
Buyback growth of 40.77% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.